OpenAlex
PricingAboutJobs
Log inGet started
Work

The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Endocrinology & Metabolism
DOI: 10.1210/jc.2006-1882
Authors: Bogdan Balas, Muhammad R. Baig, Catherine Watson, Beth E. Dunning, Monica Ligueros-Saylan, Yibin Wang, Yan-Ling He, Celia Darland, Jens J. Holst, Carolyn F. Deacon, Kenneth Cusi, Andrea Mari, James E. Foley, Ralph A. DeFronzo
Institutions: The University of Texas at San Antonio Health Science Center, Novartis (United States), University of Copenhagen, National Research Council
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: vildagliptin, DPP-4 inhibitors, type 2 diabetes, endogenous glucose production, glucagon-like peptide-1, insulin secretion, glucagon suppression, postprandial blood glucose, meal tolerance test, islet function, single-dose administration, glucose homeostasis, fasting blood glucose, dipeptidyl peptidase IV
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1970498822
FWCI: 15.92
Cites: 23
Cited by: 254
Related to: 7
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms